A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy.
Polymorphisms in the human endothelial nitric oxide synthase (eNOS) gene (NOS3) have been associated with advanced nephropathy in diabetic patients and with decreased expression in tissue culture. However, direct proof that modest genetic decreases in eNOS expression worsen diabetic nephropathy is lacking. To investigate this effect, we took advantage of the hybrid vigor and genetic uniformity of the F1 progeny (eNOS(+/+), eNOS(+/-), or eNOS(-/-) with or without diabetes) of a cross between heterozygous 129S6/SvEvTac eNOS(+/-) inbred females and heterozygous C57BL/6J eNOS(+/-) inbred males carrying the dominant Akita diabetogenic mutation Ins2(C96Y/+). Whereas all C57BL/6J inbred eNOS(-/-) and eNOS(+/-) diabetic mice died before 5 mo, almost half of the F1 hybrid eNOS(-/-) and eNOS(+/-) diabetic mice lived until killed at 7 mo. Heterozygous eNOS(+/-) diabetic mice expressed ∼35% eNOS mRNA in the kidney and ∼25% glomerular eNOS protein relative to their eNOS(+/+) diabetic littermates. These decreases in eNOS elevated blood pressure (BP) but not blood glucose. Urinary albumin excretion, mesangial expansion, glomerulosclerosis, mesangiolysis, and glomerular filtration rate increased in the order: eNOS(+/+) Akita < eNOS(+/-) Akita < eNOS(-/-) Akita, independently of BP. Glomerular basement membrane thickening depended on increased BP. Renal expression of tissue factor and other inflammatory factors increased with the nephropathy; Nos2 also increased. Surprisingly, however, decreased eNOS expression ameliorated the increases in oxidative stress and tubulointerstitial fibrosis caused by diabetes. Our data demonstrate that a modest decrease in eNOS, comparable to that associated with human NOS3 variants, is sufficient to enhance diabetic nephropathy independently of its effects on BP.
Department of Pathology and Laboratory Medicine, The University of North Carolina, Chapel Hill, NC 27599, USA.
Chih-Hong
CH
Wang
Feng
F
Li
Sylvia
S
Hiller
Hyung-Suk
HS
Kim
Nobuyo
N
Maeda
Oliver
O
Smithies
Nobuyuki
N
Takahashi
D000818:Animals; D001794:Blood Pressure; D003928:Diabetic Nephropathies / Q000201:enzymology* / Q000503:physiopathology; D005260:Female; D005337:Fibrin / Q000378:metabolism; D006801:Humans; D007668:Kidney / Q000201:enzymology / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism*; D018384:Oxidative Stress; D013925:Thromboplastin / Q000378:metabolism
D005337:Fibrin; D013925:Thromboplastin; D052250:Nitric Oxide Synthase Type III
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2547-51
9482923
J Diabetes Complications. 2008 Sep-Oct;22(5):331-8
18413207
J Am Soc Nephrol. 2002 Mar;13(3):604-610
11856763
J Am Soc Nephrol. 2006 Oct;17(10):2664-9
16971655
J Thromb Haemost. 2009 Jul;7(7):1092-8
19422446
Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13176-81
8917564
Hypertension. 1995 May;25(5):1111-5
7737724
Diabetes. 2008 Jun;57(6):1446-54
18511445
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5434-9
10779555
Am J Pathol. 2009 Apr;174(4):1221-9
19246639
Eur J Med Res. 2007 Aug 16;12(8):351-5
17933712
J Clin Pathol. 2007 Jan;60(1):18-26
17213346
Curr Diab Rep. 2002 Apr;2(2):191-200
12643139
Hypertension. 2002 Oct;40(4):535-40
12364359
Clin Sci (Lond). 2009 Mar;116(6):479-92
19200057
J Thromb Haemost. 2010 Oct;8(10):2122-32
20626618
J Am Soc Nephrol. 2005 Jan;16(1):125-32
15563565
Atherosclerosis. 2006 Nov;189(1):241-6
16427644
Thromb Haemost. 2005 Jun;93(6):1161-7
15968403
Curr Pharm Des. 2004;10(8):923-7
15032695
Am J Pathol. 2007 May;170(5):1473-84
17456755
Diabetes. 2007 Jul;56(7):1825-33
17456853
Curr Diab Rep. 2005 Dec;5(6):455-63
16316598
Circ Res. 1999 Jun 25;84(12):1416-21
10381894
Kidney Int. 2007 Feb;71(3):266-71
17149371
Clin Nephrol. 2008 Aug;70(2):144-54
18793530
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3521-5
7724593
Circulation. 1999 Sep 14;100(11):1215-22
10484543
J Am Soc Nephrol. 2007 Feb;18(2):539-50
17202420